Literature DB >> 21861088

Treatment of intractable skin ulcers caused by vascular insufficiency with allogeneic cultured dermal substitute: a report of eight cases.

Tomonori Taniguchi1, Yasuyuki Amoh, Kenichi Tanabe, Kensei Katsuoka, Yoshimitsu Kuroyanagi.   

Abstract

Chronic leg ulcers have various causes and can be difficult to treat, although topical treatments, including basic fibroblast growth factor and PGE1, have been used. We applied an allogeneic cultured dermal substitute (CDS) to eight patients with intractable ulcers. The patients had various underlying diseases, including diabetes mellitus, systemic lupus erythematosus, antiphospholipid syndrome, necrobiosis lipoidica, stasis dermatitis, livedo vasculopathy, and rheumatoid arthritis. The CDS was prepared by seeding cultured human fibroblasts on a spongy matrix consisting of hyaluronic acid and atelocollagen. Good clinical results were achieved, as demonstrated by reepithelization, healthy granulation tissue formation, and a subsequent decrease in wound size. Daily dressing changes became unnecessary when the allogeneic CDS was used. Based on these results, we suggest that CDS may be useful for the treatment of intractable skin ulcers.

Entities:  

Mesh:

Year:  2011        PMID: 21861088     DOI: 10.1007/s10047-011-0601-9

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  28 in total

1.  Intractable leg ulcers associated with antiphospholipid syndrome with stasis dermatitis: treatment with allogeneic cultured dermal substitute.

Authors:  Junko Nishimoto; Yasuyuki Amoh; Kenichi Tanabe; Nanako Niiyama; Kensei Katsuoka; Yoshimitsu Kuroyanagi
Journal:  Eur J Dermatol       Date:  2007-06-01       Impact factor: 3.328

2.  Comparative evaluation of re-epithelialization promoted by fresh or cryopreserved cultured dermal substitute.

Authors:  Naoto Yamada; Eiju Uchinuma; Yasuhiro Matsumoto; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2008-12-17       Impact factor: 1.731

3.  An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports.

Authors:  Toshio Hasegawa; Yasushi Suga; Masayuki Mizoguchi; Shigenori Muramatsu; Yuki Mizuno; Hideoki Ogawa; Kentaro Kubo; Yoshimitsu Kuroyanagi
Journal:  J Dermatol       Date:  2005-09       Impact factor: 4.005

4.  Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers.

Authors:  Masao Yonezawa; Hideaki Tanizaki; Naoko Inoguchi; Masahide Ishida; Mayumi Katoh; Takao Tachibana; Yoshiki Miyachi; Kentaro Kubo; Yoshimitsu Kuroyanagi
Journal:  Int J Dermatol       Date:  2007-01       Impact factor: 2.736

5.  Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal test.

Authors:  Kentaro Kubo; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2003       Impact factor: 1.731

6.  Digital gangrene associated with idiopathic hypereosinophilia: treatment with allogeneic cultured dermal substitute (CDS).

Authors:  Toshio Ohtani; Katsuyuki Okamoto; Chikako Kaminaka; Tomoh Kishi; Mikihisa Sakurane; Yuki Yamamoto; Koji Uede; Kentaro Kubo; Yoshimitsu Kuroyanagi; Fukumi Furukawa
Journal:  Eur J Dermatol       Date:  2004 May-Jun       Impact factor: 3.328

7.  Standardization for mass production of allogeneic cultured dermal substitute by measuring the amount of VEGF, bFGF, HGF, TGF-beta, and IL-8.

Authors:  Akiko Hashimoto; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2008-12-17       Impact factor: 1.731

8.  Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study.

Authors:  J L Richard; C Parer-Richard; J P Daures; S Clouet; D Vannereau; J Bringer; M Rodier; C Jacob; M Comte-Bardonnet
Journal:  Diabetes Care       Date:  1995-01       Impact factor: 19.112

9.  Case report: a case of pyoderma gangrenosum with intractable leg ulcers treated by allogeneic cultured dermal substitutes.

Authors:  Seiko Toyozawa; Yuki Yamamoto; Takeshi Nishide; Akiko Kishioka; Nobuo Kanazawa; Yasuhiro Matsumoto; Yoshimitsu Kuroyanagi; Fukumi Furukawa
Journal:  Dermatol Online J       Date:  2008-11-15

10.  Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers.

Authors:  M Weckroth; A Vaheri; J Lauharanta; T Sorsa; Y T Konttinen
Journal:  J Invest Dermatol       Date:  1996-05       Impact factor: 8.551

View more
  3 in total

Review 1.  Journal of Artificial Organs 2012: the year in review.

Authors:  Y Sawa; E Tatsumi; T Tsukiya; K Matsuda; K Fukunaga; A Kishida; T Masuzawa; G Matsumiya; A Myoui; M Nishimura; T Nishimura; T Nishinaka; E Okamoto; S Tokunaga; T Tomo; Y Yagi; T Yamaoka
Journal:  J Artif Organs       Date:  2013-02-28       Impact factor: 1.731

Review 2.  Cellular human tissue-engineered skin substitutes investigated for deep and difficult to heal injuries.

Authors:  Álvaro Sierra-Sánchez; Kevin H Kim; Gonzalo Blasco-Morente; Salvador Arias-Santiago
Journal:  NPJ Regen Med       Date:  2021-06-17

3.  The Effect of Control-released Basic Fibroblast Growth Factor in Wound Healing: Histological Analyses and Clinical Application.

Authors:  Shigeru Matsumoto; Rica Tanaka; Kayoko Okada; Kayo Arita; Hiko Hyakusoku; Masaaki Miyamoto; Yasuhiko Tabata; Hiroshi Mizuno
Journal:  Plast Reconstr Surg Glob Open       Date:  2013-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.